Systematic analysis of the amino acid residues of human papillomavirus type 16 E7 conserved region 3 involved in dimerization and transformation

Journal of Virology

Volumn 85, Issue 19, 2011, Pages 10048-10057

  Todorovic, Biljana ^a,c   Massimi, Paola ^b   Hung, Katherine ^a,c   Shaw, Gary S ^a   Banks, Lawrence ^b   Mymryk, Joe S ^a,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^c LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E7; RAS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL ASSAY; CONSERVED REGION 3; CONTROLLED STUDY; DIMERIZATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HYDROPHOBICITY; IN VITRO STUDY; KIDNEY CELL; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; RAT; SEQUENCE ANALYSIS; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; VIRUS CELL TRANSFORMATION; VIRUS MUTANT;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO ACIDS; ANIMALS; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; DNA MUTATIONAL ANALYSIS; HUMAN PAPILLOMAVIRUS 16; MODELS, MOLECULAR; PAPILLOMAVIRUS E7 PROTEINS; PROTEIN MULTIMERIZATION; RATS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; RATTUS;

EID: 80054003173     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00643-11     Document Type: Article

References (51)

1. Adams, A., D. E. Gottschling, C. A. Kaiser, and T. Stearns. 1997. Methods in yeast genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
2. Alonso, L. G., et al. 2004. The HPV16 E7 viral oncoprotein self-assembles into defined spherical oligomers. Biochemistry 43:3310-3317.
3. Androphy, E. J., N. L. Hubbert, J. T. Schiller, and D. R. Lowy. 1987. Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. EMBO J. 6:989-992.
4. Avvakumov, N., J. Torchia, and J. S. Mymryk. 2003. Interaction of the HPV E7 proteins with the pCAF acetyltransferase. Oncogene 22:3833-3841.
5. Baker, D., and A. Sali. 2001. Protein structure prediction and structural genomics. Science 294:93-96.
6. Banks, L., et al. 1987. Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas. J. Gen. Virol. 68:1351-1359.
7. Berezutskaya, E., and S. Bagchi. 1997. The human papillomavirus E7 oncoprotein functionally interacts with the S4 subunit of the 26S proteasome. J. Biol. Chem. 272:30135-30140.
8. Bodily, J. M., K. P. Mehta, and L. A. Laimins. 2011. Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases. Cancer Res. 71:1187-1195.
9. Braspenning, J., et al. 1998. The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cells. Oncogene 16:1085-1089.
10. Brehm, A., et al. 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597-601.
11. Brehm, A., et al. 1999. The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J. 18:2449-2458.
12. Chesters, P. M., K. H. Vousden, C. Edmonds, and D. J. McCance. 1990. Analysis of human papillomavirus type 16 open reading frame E7 immortalizing function in rat embryo fibroblast cells. J. Gen. Virol. 71:449-453.
13. Clemens, K. E., R. Brent, J. Gyuris, and K. Munger. 1995. Dimerization of the human papillomavirus E7 oncoprotein in vivo. Virology 214:289-293.
14. Clements, A., K. Johnston, J. M. Mazzarelli, R. P. Ricciardi, and R. Marmorstein. 2000. Oligomerization properties of the viral oncoproteins adenovirus E1A and human papillomavirus E7 and their complexes with the retinoblastoma protein. Biochemistry 39:16033-16045.
15. Dawar, M., S. Deeks, and S. Dobson. 2007. Human papillomavirus vaccines launch a new era in cervical cancer prevention. CMAJ 177:456-461.
16. de Villiers, E. M., C. Fauquet, T. R. Broker, H. U. Bernard, and H. zur Hausen. 2004. Classification of papillomaviruses. Virology 324:17-27.
17. Dyson, N., P. Guida, K. Munger, and E. Harlow. 1992. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J. Virol. 66:6893-6902.
18. Edmonds, C., and K. H. Vousden. 1989. A point mutational analysis of human papillomavirus type 16 E7 protein. J. Virol. 63:2650-2656.
19. Funk, J. O., et al. 1997. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev. 11:2090-2100.
20. Gietz, R. D., R. H. Schiestl, A. R. Willems, and R. A. Woods. 1995. Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. Yeast 11:355-360.
21. Gillison, M. L., et al. 2000. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 92:709-720.
22. Goodwin, E. C., and D. DiMaio. 2000. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc. Natl. Acad. Sci. U. S. A. 97:12513-12518.
23. Goodwin, E. C., et al. 2000. Rapid induction of senescence in human cervical carcinoma cells. Proc. Natl. Acad. Sci. U. S. A. 97:10978-10983.
24. Halbert, C. L., G. W. Demers, and D. A. Galloway. 1991. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 65:473-478.
25. Helt, A. M., and D. A. Galloway. 2001. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes. J. Virol. 75:6737-6747.
26. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the PCR. Gene 77:51-59.
27. Huh, K., et al. 2007. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J. Virol. 81:9737-9747.
28. Huh, K. W., et al. 2005. Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600. Proc. Natl. Acad. Sci. U. S. A. 102:11492-11497.
29. Jeon, S., B. L. Allen-Hoffmann, and P. F. Lambert. 1995. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol. 69:2989-2997.
30. Jewers, R. J., P. Hildebrandt, J. W. Ludlow, B. Kell, and D. J. McCance. 1992. Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes. J. Virol. 66:1329-1335.
31. Kammann, M., J. Laufs, J. Schell, and B. Gronenborn. 1989. Rapid insertional mutagenesis of DNA by PCR. Nucleic Acids Res. 17:5404.
32. Liu, X., A. Clements, K. Zhao, and R. Marmorstein. 2006. Structure of the human papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor. J. Biol. Chem. 281:578-586.
33. Massimi, P., and L. Banks. 2005. Transformation assays for HPV oncoproteins. Methods Mol. Med. 119:381-395.
34. McIntyre, M. C., M. G. Frattini, S. R. Grossman, and L. A. Laimins. 1993. Human papillomavirus type 18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding. J. Virol. 67:3142-3150.
35. McLaughlin-Drubin, M. E., K. W. Huh, and K. Munger. 2008. Human papillomavirus type 16 E7 oncoprotein associates with E2F6. J. Virol. 82: 8695-8705.
36. Morris, E. J., and N. J. Dyson. 2001. Retinoblastoma protein partners. Adv. Cancer Res. 82:1-54.
37. Ohlenschlager, O., et al. 2006. Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7. Oncogene 25:5953-5959.
38. Patrick, D. R., A. Oliff, and D. C. Heimbrook. 1994. Identification of a novel retinoblastoma gene product binding site on human papillomavirus type 16 E7 protein. J. Biol. Chem. 269:6842-6850.
39. Phelps, W. C., K. Munger, C. L. Yee, J. A. Barnes, and P. M. Howley. 1992. Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein. J. Virol. 66:2418-2427.
40. Phelps, W. C., C. L. Yee, K. Munger, and P. M. Howley. 1988. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 53:539-547.
41. Phillips, A. C., and K. H. Vousden. 1997. Analysis of the interaction between human papillomavirus type 16 E7 and the TATA-binding protein, TBP. J. Gen. Virol. 78:905-909.
42. Schneider-Gadicke, A., and E. Schwarz. 1987. Transcription of human papillomavirus type-18 DNA in human cervical carcinoma cell lines. Haematol. Blood Transfus. 31:380-381.
43. Smotkin, D., and F. O. Wettstein. 1987. The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein. J. Virol. 61:1686-1689.
44. Storey, A., N. Almond, K. Osborn, and L. Crawford. 1990. Mutations of the human papillomavirus type 16 E7 gene that affect transformation, transactivation and phosphorylation by the E7 protein. J. Gen. Virol. 71:965-970.
45. Vousden, K. H., and P. S. Jat. 1989. Functional similarity between HPV16E7, SV40 large T and adenovirus E1a proteins. Oncogene 4:153-158.
46. Watanabe, S., T. Kanda, H. Sato, A. Furuno, and K. Yoshiike. 1990. Mutational analysis of human papillomavirus type 16 E7 functions. J. Virol. 64:207-214.
47. Willard, L., et al. 2003. VADAR: a web server for quantitative evaluation of protein structure quality. Nucleic Acids Res. 31:3316-3319.
48. Zerfass-Thome, K., et al. 1996. Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene 13:2323-2330.
49. Zhang, Z., M. M. Smith, and J. S. Mymryk. 2001. Interaction of the E1A oncoprotein with Yak1p, a novel regulator of yeast pseudohyphal differentiation, and related mammalian kinases. Mol. Biol. Cell 12:699-710.
50. zur Hausen, H. 1996. Papillomavirus infections-a major cause of human cancers. Biochim. Biophys. Acta 1288:F55-F78.
51. Zwerschke, W., S. Joswig, and P. Jansen-Durr. 1996. Identification of domains required for transcriptional activation and protein dimerization in the human papillomavirus type-16 E7 protein. Oncogene 12:213-220.